Author Archives: admin

Effects of Spaceflight on Astronaut Brain Structure as Indicated on MRI

November 22, 2017 – Interviewed by Steven E. Greer, MD We interviewed Donna Roberts, MD of the Medical University of South Carolina about her NEJM paper

Posted in - NEJM, Medical University of South Carolina, Neurology, Neurosurgery, Ophthalmology, Radiology | Leave a comment

Increasing rates of double mastectomies in early stage breast cancer

November 22, 2013- Interviewed by Steven E. Greer, MD David P. Winchester MD, Medical Director of Cancer Programs for the American College of Surgeons,

Posted in - Policy, Oncology, Plastic surgery | Leave a comment

The Gluten Crazies are out of control and affecting menus in restaurants

April 26, 2015- By Steven E. Greer, MD I was eating at a French restaurant recently, and the waiter asked me if I had any allergies, such as “gluten”.

Posted in - Opinion, Gastroenterology and liver, Harvard, Pediatrics | Leave a comment

The Weekly Summary

January 8th – January 14th                                 2018 In general news, people in Hawaii were scared by an erroneous public service warning that a

Posted in - The Weekly Summary | Leave a comment

The serious adverse events caused by antipsychotics

February 1, 2014

Posted in - Pharma, FDA | Leave a comment

The Weekly Summary

January 1st – January 7th                                 2018 In general news, anti-government protests by young moderates in Iran grew. More record

Posted in - The Weekly Summary | Leave a comment

Steve Bannon and the epidemic of Baby Boomers with mental illness

January 5, 2017- by Steven E. Greer, MD President Trump made news yesterday by issuing a statement firing back at Steve Bannon for allegations

Posted in - Opinion, - Pharma, - Policy, Geriatrics, Neurology, Psychology Psychiatry, Rehab | Leave a comment

Ocrelizumab (Ocrevus) versus Placebo in Primary Progressive Multiple Sclerosis

January 31, 2017- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Pharma, Neurology, Univ Texas | 1 Comment

How pain pills almost killed my mother after elective knee surgery

May 21, 2014- By Steven E. Greer, MD My mother is in her 70’s and in good health except for debilitating knee arthritis. After considerable

Posted in - Opinion, - Policy, CDC, Congress, FDA, Orthopedic surgery, Plastic surgery | Leave a comment

Hormone replacement therapy is safe and effective after all

November 14, 2017- Interviewed by Steven E. Greer, MD We interviewed JoAnn Manson, MD, DrPH about her JAMA paper that followed the cohorts in

Posted in - JAMA, Cardiology, Diabetes and endocrinology, FDA, Geriatrics, Harvard, Obstetrics and Gynecology, Oncology, Orthopedic surgery, Primary care medicine | Leave a comment

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer (FLAURA)

November 20, 2017- Interviewed by Steven E. Greer, MD We interviewed Emory University oncologist Suresh S. Ramalingam, M.D. about his NEJM

Posted in - NEJM, Cardiac surgery, Emory, Oncology | Leave a comment

CT-scan screening for heart disease fails to show benefit

March 23, 2015- Interviewed by Steven E. Greer, MD We interviewed the Principal Investigator of the PROMISE trial, Pamela Douglas, MD from Duke.

Posted in - NEJM, - Policy, Cardiology, CMS, Duke, Radiology | Leave a comment

What Steve Jobs would have invented if he had lived longer

Update January 29, 2014- Apple posted Q4 earnings so big that they are incomprehensible.

Posted in - Medical Devices, - Opinion | Leave a comment

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

May 23, 2017- interviewed by Steven E. Greer, MD We interviewed polumonologist Michael Wechsler, MD about his paper in the NEJM testing mepolizumab

Posted in - NEJM, National Jewish Health, Pulmonology, Rheumatology | Leave a comment

The super shady methods of pricing generic drugs in America: case study- Sildenafil

May 15, 2016- by Steven E. Greer, MD The last I read, Teva and Mylan were not supposed to launch their approved generic of Viagra (sildenafil)

Posted in - Generics, - Opinion, - Pharma, CMS, Congress, FDA | Leave a comment

What 1982’s Blade Runner got right about 2019

September 3, 2017- by Steven E. Greer, MD I watched again the 1982 classic Blade Runner. Directed by Ridley Scott and starring Harrison Ford,

Posted in - Opinion, - Reviews, books, devices, Genetics, Geriatrics, Obstetrics and Gynecology, Oncology, Ophthalmology | Leave a comment

Review of immunotherapy and targeted therapy

June 17, 2016- interviewed by Steven E. Greer, MD We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, to go over the

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

Maybe my brain was spared

July 26, 2017- by Steven E. Greer, MD Last week, I sat next to an Ohio State University offensive lineman while attending a Roger Waters

Posted in - JAMA, - Reviews, books, devices, Neurology, Neurosurgery, Ohio State, Ohio State | 1 Comment

Current surgical weight loss therapies

January 24, 2014- Interviewed by Steven E. Greer, MD Erik Dutson, MD, weight loss surgeon at UCLA, explains why his medical center does not implant the Lap-Band,

Posted in - Medical Devices, Bariatric surgery, General surgery, UCLA | Leave a comment

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

February 27, 2017- interviewed by Steven E. Greer, MD We interviewed Joaquim Bellmunt, MD, PhD, the Director of the Bladder Cancer Center at Dana-Farber,

Posted in - Biotech, - NEJM, - Pharma, Harvard, Oncology | Leave a comment